Connect with us

Emerging Markets

General European Strategic Investments (OTCMKTS: GESI) Waiting for a BOUNCE as Promo Ends and Investors Run for the Exits

Published

on

General European Strategic Investments (OTCMKTS: GESI) has ended up just where we said it would in our first report on the Company recently moving well below $0.20 per share; a far cry from the $10 plus levels this stock reached in mid-June at the height of the The-FinancialNews.com linked google add campaign. We stated then the GESI has a powerful promoter behind it who may continue to push it much higher, but the bottom will drop out, GESI is not SEC reporting and cannot maintain this valuation. The steady ride up every day on plenty of liquidity is nice but be careful when the bottom drops out, it will happen very fast.” and it did happen very fast, too fast for the many shareholders who bought on the way up and GESI is currently down well over 95% from its June highs. 

We also reported on the skull & crossbones designation from OTCMarkets was another nail in the coffin for GESI which can no longer issue press releases as a result. With the ad campaign long over, and investors jumping ship all that GESI is good for now is bounces and it will bounce. The stock has dropped from over $10 per share and there will be a significant short covering rally as soon as the stock reverses. Where will that happen is hard to say, the stock could easily drop much farther before the reversal. Smart investors will wait on the sidelines until a significant reversal has been established and even then, investors should be very careful with GESI especially holding the stock overnight. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

General European Strategic Investments (OTCMKTS: GESI) holds a significant interests in Tier-1 and district-scale projects, located in Europe. The portfolio of GESI includes: Gemerska Poloma – Arbitration Case, Laakso PGE-Nickel-Copper Project, ColdPro LTD and the Transcarpathian Gold Project. The Comapany has issued many press releases over the past few months but if you want to skip these because really the don’t mean anything, then skip to the conclusion that start with “currently trading at a $109 million market valuation in bold;

GESI recently brought on Christopher Malone to its new CFO. Wolfgang Rauball, GESI’s CEO, stated, “Mr. Appleby has recently had a significant increase in his workload, and as our company is maturing and evolving its business at a more rapid pace, he felt it would be in the best interest of the company and its shareholders to step down from the position of CFO. We would like to thank him for his hard work and I am pleased he will be able to continue as an independent member of our Board of Directors, and we look forward to working with him in that capacity as he brings valuable insight given his experience in the industry. However, the position of CFO is being left in good hands, as Mr. Malone also has extensive financial experience and having them both on the board is a valuable asset to our overall team.” 

Christopher Malone was unanimously approved by the board to fill the CFO position, and he is the founding Director of PrOasis, a professional consulting firm, where he has spent the past 31 years managing the firm which focuses on executive management, corporate finance, strategic planning and governance for major Canadian SME organizations. Mr. Malone currently holds the positions as Chief Financial Officer and Director for an OSC registered Fund Manager and an IIROC registered Broker Dealer member. He has extensive listing, regulatory reporting and governance experience with private businesses and public companies and Exchanges in Canada and the United States. Mr. Malone’s experience stems from over 39 years in the North American workforce holding senior financial and information technology systems roles in some of Canada’s largest domestic and multi-national organizations. He also holds a CPA/CMA designation and graduated from the University of Western Ontario with a B.A. in Commerce and Economics. 

  To Find out the inside Scoop on GESI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

GESI

GESI recently reported the signing of the Consortium Agreement for the Seismic and Electromagnetic Methods for Deep Mineral Exploration Project (“SEEMS DEEP”). GESI participates in the SEEMS DEEP Project through its wholly owned Finnish subsidiary Laakso Minerals Oy (“Laakso”). The Consortium Agreement of the SEEMS DEEP Project has been signed by all the Parties and has come into force. 

The Parties include: the Geological Survey of Finland (GTK); Uppsala University, Department of Earth Sciences, Sweden; Bureau des Recherches Géologiques et Minières (BRGM), France; Institute of Geophysics, Polish Academy of Sciences; Geopartner Geofizyka sp. z. o.o., Poland; GRM-Services, Finland; IRIS Instruments, France; Laakso Minerals Oy, Finland. 

The Consortium Agreement specifies the relationship among the Parties, concerning the organization of the work between them, the management of the Project and the rights and obligations of the Parties concerning inter alia liability, access rights and dispute resolution. 

Being now in full force, the Consortium Agreement shall continue and be in effect until complete fulfilment of all obligations undertaken by the Parties under the ERA-MIN3 funding rules. Presentation of the first scientific results of the SEEMS DEEP Consortium will take place between the 18-22 September this year at the 4th Conference on Geophysics for Mineral Exploration and Mining of the European Association of Geoscientists and Engineers in Belgrad, Serbia. 

Wolfgang Rauball, GESI’s CEO, stated, “The SEEMS DEEP Project and the results of the unique Koillismaa Deep Hole, being drilled by the Geological Survey of Finland within the Laakso’s reservation permit, will result in construction of high-confidence geomodel describing the geological structure of the large positive gravity and magnetic anomaly that potentially acted as a conduit for the mafic-ultramafic magma, which formed the nickel, cobalt and platinum group metals mineralization in the region. It is hopped that this work will define the potential for high-grade nickel, cobalt and platinum group mineralization at depth within the Korpuajärvi land-holding of Laakso Minerals Oy. The work on geomodelling has already started and we look forward to providing further updates.” 

 

 Big Picks Coming, Subscribe Now

Currently trading at a $109 million market valuation GESI started trading in late April at $5 per share and it has been a volatile ride since then, dropping to as low as $0.84 in early April the stock traded over $10 per share in June before a massive crash to current levels. GESI has had the dreaded skull and crossbones designation added by OTCMarkets due to the promotion that used an aggressive google add campaign leading to changing numbered pages at The-FinancialNews.com. As we said before; the reality is that GESI does not support a market valuation of more than $15 to $30 million which means the stock will be trading for pennies in the end. Currently dropping under $0.20, there will be a significant short covering rally as soon as the stock reverses. Where will that happen is hard to say, the stock could easily drop much farther before the reversal. Smart investors will wait on the sidelines until a significant reversal has been established and even then, investors should be very careful with GESI especially holding the stock overnight. We will be updating on GESI when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in GESI either long or short and we have not been compensated for this article

 

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.